Intrahepatic cholangiocarcinoma Cancer
Conditions
Interventions
Our research is an observation study. No intervention was involved in the course of the study. We collected tissue samples from patients attending the Department of Pathology of Zhongshan Hospital. Th
Sponsors
Zhongshan Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Age >20 years old 2. Male/female 3. Primary Intrahepatic Cholangiocarcinoma in patients who received curative resection
Exclusion criteria
Exclusion criteria: 1. Patients receiving palliative surgeries, prior interventions or with other primary malignancies and inflammatory diseases during the follow-up were excluded from the study 2. Patients with further lymph node involvement were considered to have distant metastasis and were excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Disease-free survival (DFS), defined as the interval between the surgery and any diagnosis of recurrence, measured using data collected every 3 months in the clinical information database of Zhongshan Hospital at one timepoint 2. Overall survival (OS), defined as the time from the date of surgery until death or to the end of follow-up, measured using data collected every 3 months in the clinical information database of Zhongshan Hospital at one timepoint | — |
Secondary
| Measure | Time frame |
|---|---|
| Gene mutation measured using whole-exome sequencing or Sanger sequencing at one timepoint | — |
Countries
China
Outcome results
None listed